Allopurinol does not improve cardiovascular outcomes in ischaemic heart disease-Reference-Cited by-同舟云学术

Allopurinol does not improve cardiovascular outcomes in ischaemic heart disease

Published:2023-02-03 Issue:12 Volume:44 Page:1016-1017
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Liuzzo Giovanna¹²^ORCID,Patrono Carlo³^ORCID

Affiliation:

1. Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli—IRCCS , Largo A. Gemelli 8, Rome 00168, Lazio , Italy

2. Cardiovascular and Pulmonary Sciences, Catholic University, School of Medicine , Largo F. Vito, 1–00168 Rome, Lazio , Italy

3. Pharmacology, Catholic University School of Medicine , Largo F. Vito, 1–00168 Rome, Lazio , Italy

Funder

Italian Minister of Health RC 2022

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

https://academic.oup.com/eurheartj/article-pdf/44/12/1016/49570899/ehad014.pdf

Reference12 articles.

1. Allopurinol versus usual care in patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial;Mackenzie;Lancet,2022

2. Xanthine oxidase and its role as target in cardiovascular disease: cardiovascular protection by enzyme inhibition?;Schuchardt;Curr Pharm Des,2017

3. Carotid plaques from symptomatic patients are characterized by local increase in xanthine oxidase expression;Ganji;Stroke,2021

4. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress;McNally;Am J Physiol,2003

5. Identification of the uric acid thresholds predicting an increased total and cardiovascular mortality over 20 years;Virdis;Hypertension,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of heart failure and chronic kidney disease protection by SGLT2 inhibitors in nondiabetic conditions;American Journal of Physiology-Cell Physiology;2024-09-01

2. Allopurinol for Secondary Prevention in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Journal of Cardiovascular Development and Disease;2023-09-04

3. Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA);European Journal of Medical Research;2023-07-17